[Therapy of depressive states with hypericin].
D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001551:Benz(a)Anthracenes / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010569:Perylene / Q000031:analogs & derivatives / Q000627:therapeutic use*; D010616:Phenanthrenes / Q000031:analogs & derivatives / Q000627:therapeutic use; D010919:Placebos; D013997:Time Factors
D000928:Antidepressive Agents; D001551:Benz(a)Anthracenes; D010616:Phenanthrenes; D010919:Placebos; D010569:Perylene
Therapie von depressiven Zuständen mit Hypericin.